Trial Profile
Effects of periprocedural atorvastatin therapy on patients undergoing percutaneous coronary intervention (PCI)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Angina pectoris; Coronary artery disease
- Focus Pharmacodynamics
- Acronyms ATTICA
- 02 Sep 2015 Results (10-year Follow-up) presented at the ESC Congress 2015: Annual Congress of the European Society of Cardiology
- 02 Jun 2011 Planned End Date changed to 16 Apr 2010.
- 01 Jun 2011 New trial record